Janux Therapeutics Q4 EPS $(0.39) Beats $(0.49) Estimate, Sales $2.85M Beat $790.00K Estimate
Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.49) by 20.41 percent. This is a 18.18 percent decrease over losses of $(0.33) per share